Bremelanotide is used for :
Bremelanotide (BMT), a novel heptapeptide melanocoin-receptor-4 agonist, given subcutaneously, yielded improvements in the number of satisfying sexual events, frequency, and intensity of desire and a reduction in distress over level of sexual desire. Ref: KD Tripathi 8th ed
Erectile dysfunction
Lower urinary tract symptoms
Prostate Cancer
Metastatic renal cancer
Other topics and Adverse effects